The results demonstrated that the restoration of BRD7 effectively rescued the inhibition of proliferation, tumor growth, and paclitaxel chemosensitivity mediated by TRIM25 silencing in vitro and in vivo, emphasizing that TRIM25 regulated the malignant progression and PTX resistance of BC in a BRD7-dependent manner. Here, TRIM25 is linked to neoplasm.